1. Home
  2. IMPP vs PROF Comparison

IMPP vs PROF Comparison

Compare IMPP & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imperial Petroleum Inc.

IMPP

Imperial Petroleum Inc.

HOLD

Current Price

$5.31

Market Cap

234.7M

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

N/A

Current Price

$6.82

Market Cap

263.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMPP
PROF
Founded
1981
N/A
Country
Greece
Canada
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.7M
263.8M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
IMPP
PROF
Price
$5.31
$6.82
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
358.1K
103.0K
Earning Date
05-22-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.89
EPS
N/A
N/A
Revenue
N/A
$16,098,000.00
Revenue This Year
$51.79
$92.40
Revenue Next Year
$6.97
$64.10
P/E Ratio
$3.68
N/A
Revenue Growth
N/A
50.73
52 Week Low
$3.15
$3.92
52 Week High
$6.57
$8.95

Technical Indicators

Market Signals
Indicator
IMPP
PROF
Relative Strength Index (RSI) 59.91 46.50
Support Level $4.64 $6.47
Resistance Level $5.30 $7.04
Average True Range (ATR) 0.22 0.32
MACD 0.04 -0.01
Stochastic Oscillator 76.67 37.78

Price Performance

Historical Comparison
IMPP
PROF

About IMPP Imperial Petroleum Inc.

Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: